Patients’ Right to Know Their Medication Act of 2022
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jan 28, 2022)
Patients' Right to Know Their Medication Act of 2022
This bill requires the Food and Drug Administration (FDA) to issue regulations concerning the patient medication information that is included in the labeling for prescription medications.
The regulations must impose various requirements, such as requiring the information to (1) be scientifically accurate and approved by the FDA; (2) include general directions for proper use and warnings that are written in understandable plain language; (3) contain information about known clinically important interactions with drugs, food, and other substances; (4) include a statement of whether there is sufficient data about the drug's use by specified subpopulations, such as children or pregnant women; and (5) be provided in a printed format with each prescription dispensed.
The bill prohibits prescription medications that fail to meet this bill's requirements.
What just happenedJan 31, 2022
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJan 28, 2022
- Jan 31, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 28, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jan 28, 2022IntroReferralIntro-H
Introduced in House
- Jan 28, 2022IntroReferral1000
Introduced in House